Trademarkia Logo

Australia

AU$
RYFLECTA
Cancelled: Cancelled at the request of IB

Last updated on 9 Nov 2017

Owner Info

Millennium Pharmaceuticals, Inc.

40 Landsdowne Street

Cambridge MA 02139, UNITED STATES OF AMERICA

Serial Number

1561345 filed on 5 Apr 2013

Correspondent

Takeda GmbH

Byk-Gulden-Str. 2 78467 Konstanz,

GERMANY,

RYFLECTA

Classification Information


Class [005]
Pharmaceuticals for the prevention and treatment of cancer and of auto-immune and inflammation diseases

Mark Details


Serial Number

1561345

Registered On

5 Apr 2013

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

14 Dec 2012

Mark Type

US

Legal History


Show more

Status DateAction Taken
9th Nov 2017Cancellation of Entry in Register Published
2th Nov 2017Cancel IP Right
10th Aug 2017General Correspondence (Application or Registration)
7th May 2015Amendment to Application/Registration
3rd Mar 2014Amend Name/Address
20th Feb 2014Amendment to Application/Registration
5th Sept 2013IP Right Registration Published
28th Aug 2013Register Trade Mark
28th Aug 2013Application Status
20th Jun 2013IP Right Acceptance Published